Correlation Between Bank of America and Ayala Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bank of America and Ayala Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Ayala Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Ayala Pharmaceuticals, you can compare the effects of market volatilities on Bank of America and Ayala Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Ayala Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Ayala Pharmaceuticals.

Diversification Opportunities for Bank of America and Ayala Pharmaceuticals

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bank and Ayala is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Ayala Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ayala Pharmaceuticals and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Ayala Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ayala Pharmaceuticals has no effect on the direction of Bank of America i.e., Bank of America and Ayala Pharmaceuticals go up and down completely randomly.

Pair Corralation between Bank of America and Ayala Pharmaceuticals

If you would invest  3,752  in Bank of America on January 29, 2024 and sell it today you would earn a total of  31.00  from holding Bank of America or generate 0.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy4.76%
ValuesDaily Returns

Bank of America  vs.  Ayala Pharmaceuticals

 Performance 
       Timeline  
Bank of America 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bank of America are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Bank of America exhibited solid returns over the last few months and may actually be approaching a breakup point.
Ayala Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ayala Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Ayala Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Bank of America and Ayala Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bank of America and Ayala Pharmaceuticals

The main advantage of trading using opposite Bank of America and Ayala Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Ayala Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ayala Pharmaceuticals will offset losses from the drop in Ayala Pharmaceuticals' long position.
The idea behind Bank of America and Ayala Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets